Search Protocols under revision. Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapyHematologic NeoplasmsSolid TumorsProtocol groupPlasma cell neoplasmsSarcomasTransplantationDiseaseEwing SarcomaMultiple MyelomaStem Cell Transplantation, AutologousSubgroupICD10C40.-C41.-C90.-C90.0-Z94.80MeSHPlasmacytomaSarcoma, EwingTransplantation, AutologousSequenceEWING 2012 Arm A VIDEEWING 2012 Arm B VDC/IEChemotherapyChemo-substanceChemo-substanceChemo-substanceChemo-substanceNo. Substances RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionBusulfanCiprofloxacinCotrimoxazoleDexamethasoneFosaprepitantGranisetronLevetiracetamMelphalanUrsodeoxycholic acidValaciclovirSupportive substanceBalanced Crystalloid SolutionBusulfanCiprofloxacinCotrimoxazoleDexamethasoneFosaprepitantGranisetronLevetiracetamMelphalanUrsodeoxycholic acidValaciclovirSupportive substanceBalanced Crystalloid SolutionBusulfanCiprofloxacinCotrimoxazoleDexamethasoneFosaprepitantGranisetronLevetiracetamMelphalanUrsodeoxycholic acidValaciclovirSupportive substanceBalanced Crystalloid SolutionBusulfanCiprofloxacinCotrimoxazoleDexamethasoneFosaprepitantGranisetronLevetiracetamMelphalanUrsodeoxycholic acidValaciclovirNo. Substances811Protocol classificationTherapy classificationcurrent standardIntensityHochdosis, bei autologer SZTTherapy indicationFirst lineseveral possibleTherapy phaseautologous stem cell transplantationTherapy intentioncurativeRisksEmetogenicityEmetogenicity (MASCC/ESMO) only studiesPublicationAuthorAnderton JAttal MDiseaseAuto-SZT beim MMEwing Sarkom, ErstlinieOriginEuro Ewing 2012 protocolInstitut Universitaire du Cancer de Toulouse-Oncopole and Service d'Epidemiologie, Centre Hospitalier et Universitaire de Toulouse, Toulouse, FranceProtokolle in Überarbeitung 2 protocols foundRevision: Busulfan 0,8 / Melphalan 140, autologe Stammzelltransplantation (PID571 V1.2)Revision: Melphalan 100, multiples Myelom, autologe Stammzelltransplantation (PID528 V2.3)
